Mycoplasma Genitalium Control Panel (Microbiologics) – Release Testing Problem (2022)
This recall may present a risk under certain conditions.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Mycoplasma genitalium Control Panel (Inactivated Pellet)
Brand
Microbiologics Inc
Lot Codes / Batch Numbers
Catalog 8240, Lots: 8240-08, 8240-09, 8240-10, 8240-11, 8240-12, 8240-13, 8240-14, 8240-15, 8240-16 (UDI: 70845357043053)
Products Sold
Catalog 8240, Lots: 8240-08, 8240-09, 8240-10, 8240-11, 8240-12, 8240-13, 8240-14, 8240-15, 8240-16 (UDI: 70845357043053)
Microbiologics Inc is recalling Mycoplasma genitalium Control Panel (Inactivated Pellet) due to Distributed product did not undergo proper release testing.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Distributed product did not undergo proper release testing.
Recommended Action
Per FDA guidance
All consignees were contacted beginning 02/25/2022 via email. Consignees should read the recall instructions and determine if the product can be used or discarded, depending on user's lab procedures. A response form should be completed and returned to recall@microbiologics.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AZ, CT, FL, IL, IN, KS, KY, MD, MA, NH, NJ, NY, NC, PA, TX, UT, WA, DC
Page updated: Jan 10, 2026